Peizhi Miao

Statistics

Publications

Citations

649

H-Index

Active since

2009

Affiliations

Shanghai Xuhui Central Hospital(Current)

Bayer (Germany)

University of Alberta

National University Heart Centre Singapore

Fudan University

Peizhi Miao is an author at Shanghai Xuhui Central Hospital specializing in cardiovascular pharmacotherapy, heart failure pharmacotherapy, and cardiology.

Publications per year

2009–2025

Publications

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan et al. · The Lancet Diabetes & Endocrinology · 2017 · 320 citations

Medicine, Cardiology, Pharmacology +16

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event

Carolyn S.P. Lam, Anna Giczewska, Karen Sliwa et al. · JAMA Cardiology · 2020 · 82 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom et al. · The Lancet · 2025 · 64 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Glucagon-like peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of monocytes to human endothelial cells: An implication in the treatment of atherosclerosis

Wei Chun Chang, Fu Zhu, Hongchao Zheng et al. · Molecular Immunology · 2019 · 57 citations

Life Sciences, Endocrinology, Pharmacology +16

Therapeutic monitoring of serum digoxin for patients with heart failure using a rapid LC-MS/MS method

Shuijun Li, Gangyi Liu, Jingying Jia et al. · Clinical Biochemistry · 2009 · 43 citations

Pharmacy, Cardiology, Pharmacology +15

1–5 of 10